Navigation Links
Revolutionary Pill Cuts Risk of Breast Cancer

The next five to ten years may see the development of a new contraceptive pill that reduces breast cancer risk as well as heart disease. It also has the added benefit of eliminating periods. //

The Combined Pill, currently available to women around the world is a combination of estrogen and progesterone. Estrogen however increases the risk of breast cancer and heart problems such as deep vein thrombosis.

Another, progesterone only drug, currently available in Britain also carries a risk of breast cancer mainly because of the progesterone in it.

The revolutionary new Pill uses a class of compounds known as the Progesterone Receptor Modulators (PRMs). These PRMs prevent the secretion of progesterone, which helps to maintain pregnancy.

As it neither contains estrogen nor progesterone but rather blocks the production of the latter, risks of breast cancer and heart problems are significantly reduced. Unlike the currently available drugs this new Pill also stops periods completely.

The new Pill could also herald an era of freedom from premenstrual symptoms and even endometriosis.

Professor David Baird, emeritus professor of reproductive endocrinology at the University of Edinburgh, has revealed that these PRMs were clinically tested on small groups of women with positive results and minimal side effects.

Teams in Sweden, Chile and the US have also worked on similar projects with the same compounds.

However experts warn that pro-life groups and the US Bush administration were hampering progress on the development of the new Pill as the new compound was developed on the basis of the RU486 abortion pill.

Pharmaceutical companies were also reluctant to market this drug for the very same reason.

Scientists claim that the development of this new Pill could bring transformations for millions of women. It would also reduce the risks of breast cancer and heart pr oblems, which accompany the currently available contraceptive pills.


Related medicine news :

1. Revolutionary Simple Pregnancy Blood Test Can Save Both Mother And Child
2. A Revolutionary New Treatment For Cancer Available In Australia
3. New Revolutionary Drug Could Stop the Spread of HIV
4. Revolutionary New Treatment Plan Developed For Treatment Of Unexplained Symptoms
5. Revolutionary Net To Control Malaria
6. Revolutionary Net To Control Malaria
7. Revolutionary Eye Cancer Treatment
8. Revolutionary Pill Promises Relief for Hay Fever Sufferers
9. Consensus on "Combination Therapy" for Breast Cancer
10. Breast cancer treatment to be determined by gene test
11. Breast Feeding prevents obesity later on in life
Post Your Comments:

(Date:6/26/2016)... , ... June 26, 2016 , ... On June 10-11, ... of the 2016 Cereal Festival and World’s Longest Breakfast Table in Battle Creek, MI, ... the city’s history as home to some of the world’s leading providers of cereal ...
(Date:6/26/2016)... ... June 26, 2016 , ... PawPaws brand pet supplements ... was developed to enhance the health of felines. The formula is all-natural and is ... herbs in the PawPaws Cat Kidney Support Supplement Soft Chews are Astragalus ...
(Date:6/26/2016)... Lake Orion, Clarkston, Michigan (PRWEB) , ... June ... ... direction with respect to fertility once they have been diagnosed with endometriosis. These ... tolerable intercourse but they also require a comprehensive approach that can help for ...
(Date:6/25/2016)... Austin, TX (PRWEB) , ... June 25, 2016 , ... ... Fellow of the American College of Mohs Surgery and to Dr. Russell Peckham for ... popular and highly effective treatment for skin cancer. The selective fellowship in Mohs Micrographic ...
(Date:6/25/2016)... ... June 25, 2016 , ... "With 30 hand-drawn hand gesture animations, ... Christina Austin - CEO of Pixel Film Studios. , ProHand Cartoon’s package transforms ... Final Cut Pro X . Simply select a ProHand generator and drag it above ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... KNOXVILLE, Tenn. , June 24, 2016 /PRNewswire/ ... market providing less invasive and more durable cerebrospinal ... million in funding.  The Series-A funding is led ... the Lighthouse Fund, and other private investors.  Arkis, ... less-invasive neurosurgical instrumentation and the market release of ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... Capricor Therapeutics, Inc. ... company focused on the discovery, development and commercialization ... in its ongoing randomized HOPE-Duchenne clinical trial (Halt ... its 24-patient target. Capricor expects the trial to ... 2016, and to report top line data from ...
Breaking Medicine Technology: